Literature DB >> 33558491

Effects of tetrahedral framework nucleic acid/wogonin complexes on osteoarthritis.

Shi Sirong1, Chen Yang2, Tian Taoran1, Li Songhang1, Lin Shiyu1, Zhang Yuxin1, Shao Xiaoru1, Zhang Tao1, Lin Yunfeng1, Cai Xiaoxiao3.   

Abstract

Osteoarthritis, a disorder characterized by articular cartilage deterioration, varying degrees of inflammation, and chondrocyte apoptosis, is the most common chronic joint disease. To slow or reverse its progression, inflammation should be inhibited, and chondrocyte proliferation should be promoted. Tetrahedral framework nucleic acids can be internalized by chondrocytes (even inflammatory chondrocytes) and can enhance their proliferation and migration. Wogonin, a naturally occurring flavonoid, suppresses oxidative stress and inhibits inflammation. In this study, tetrahedral framework nucleic acids were successfully self-assembled and used to load wogonin. We confirmed the effective formation of tetrahedral framework nucleic acid/wogonin complexes by dynamic light scattering, zeta potential analysis, transmission electron microscopy, and fluorescence spectrophotometry. Tetrahedral framework nucleic acids, wogonin, and especially tetrahedral framework nucleic acid/wogonin complexes effectively alleviated inflammation in vitro and in vivo and prevented cartilage destruction. In addition, these materials remarkably downregulated the expression of inflammatory mediators and matrix metalloproteinases, upregulated chondrogenic markers, and promoted tissue inhibitor of metalloproteinase 1 and B-cell lymphoma 2 expression. In vivo, after treatment with tetrahedral framework nucleic acid/wogonin complexes, the bone mineral density in regenerated tissues was much higher than that found in the untreated groups. Histologically, the complexes enhanced new tissue regeneration, significantly suppressed chondrocyte apoptosis, and promoted chondrogenic marker expression. They also inhibited cell apoptosis, increased chondrogenic marker expression, and suppressed the expression of inflammatory mediators in osteoarthritis. Therefore, we believe that tetrahedral framework nucleic acid/wogonin complexes can be used as an injectable form of therapy for osteoarthritis.

Year:  2020        PMID: 33558491     DOI: 10.1038/s41413-019-0077-4

Source DB:  PubMed          Journal:  Bone Res        ISSN: 2095-4700            Impact factor:   13.567


  51 in total

Review 1.  Osteoarthritis.

Authors:  David J Hunter; David T Felson
Journal:  BMJ       Date:  2006-03-18

Review 2.  Clinical practice. Osteoarthritis of the knee.

Authors:  David T Felson
Journal:  N Engl J Med       Date:  2006-02-23       Impact factor: 91.245

3.  Nephrogenic hepatic dysfunction: secondary to tumefactive xanthogranulomatous pyelonephritis.

Authors:  S E Vermillion; C G Morlock; L G Bartholomew; P P Kelalis
Journal:  Ann Surg       Date:  1970-01       Impact factor: 12.969

4.  Anterior Cruciate Ligament Transection-Induced Cellular and Extracellular Events in Menisci: Implications for Osteoarthritis.

Authors:  Jing Xie; Demao Zhang; Yunfeng Lin; Quan Yuan; Xuedong Zhou
Journal:  Am J Sports Med       Date:  2018-03-07       Impact factor: 6.202

5.  KDM6A promotes chondrogenic differentiation of periodontal ligament stem cells by demethylation of SOX9.

Authors:  Pingting Wang; Yanjing Li; Tingting Meng; Junjiang Zhang; Yuanyuan Wei; Zhaosong Meng; Yunfeng Lin; Dayong Liu; Lei Sui
Journal:  Cell Prolif       Date:  2017-11-23       Impact factor: 6.831

Review 6.  Transcriptional regulation of bone and joint remodeling by NFAT.

Authors:  Despina Sitara; Antonios O Aliprantis
Journal:  Immunol Rev       Date:  2010-01       Impact factor: 12.988

7.  OARSI-FDA initiative: defining the disease state of osteoarthritis.

Authors:  N E Lane; K Brandt; G Hawker; E Peeva; E Schreyer; W Tsuji; M C Hochberg
Journal:  Osteoarthritis Cartilage       Date:  2011-03-23       Impact factor: 6.576

8.  Peroxiredoxin 4 inhibits IL-1β-induced chondrocyte apoptosis via PI3K/AKT signaling.

Authors:  Zhitao Rao; Shuqing Wang; Jiaqi Wang
Journal:  Biomed Pharmacother       Date:  2017-04-06       Impact factor: 6.529

Review 9.  Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!).

Authors:  F Berenbaum
Journal:  Osteoarthritis Cartilage       Date:  2012-11-27       Impact factor: 6.576

10.  Current interventions in the management of knee osteoarthritis.

Authors:  Dinesh Bhatia; Tatiana Bejarano; Mario Novo
Journal:  J Pharm Bioallied Sci       Date:  2013-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.